Strong Hearts: A Remote, App-Enabled, Exercise Program for Patients With Congenital Heart Disease (Strong Hearts App)
Stopped early · Not applicable
Conditions studied: Congenital Heart Disease
In brief
The overall goal of this program is to create a remote, mobile application enabled exercise program for patients with Congenital Heart Disease (CHD). Pilot trials will consist of a remote exercise program with app-embedded exercise modules designed to promote and encourage safe and healthy exercise habits across a range of CHD anatomies. This app-enabled program will allow for real time data collection integrating wearable devices, as well as compliance and safety monitoring to enhance research capabilities. The app-enabled program will be versatile and may be applied in the future to patients with non-cardiac conditions.
Key facts
- Study ID
- NCT05853705
- Run by
- Duke University
- People needed
- 9
- Starts
- 2024-01-12
- Expected to finish
- 2024-12-05
- Last updated by the study team
- 2026-08-05
Who can join
Age: 10 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Repaired or unrepaired Congenital Heart Disease (CHD)
- Between ages 10 and 50, inclusive, at time of consent
- Android or Apple smartphone that meets the operating systems below with the ability to download applications from either Google Play or the Apple store
- Android: 6.0 or higher
- Apple: iPhone Operating System (iOS) 13 or higher
You may not qualify if…
- Physical or mental disabilities preventing exercise participation
- Uncontrolled systemic hypertension (symptomatic or greater than Stage 2 hypertension while on therapy)
- Poorly controlled arrhythmia
- Clinically unstable heart failure
- Known pregnancy at the time of enrollment
Where it is running
- Duke University Medical Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.